EU/ACP/WHO Renewed Partnership 3rd year meeting
29 June to 3 July 2015, Brazzaville, Congo
The EU/ACP/WHO Renewed Partnership (RP) to strengthen pharmaceutical systems and improve access to quality medicines in 15 African countries from the African, Caribbean and Pacific Group of States (ACP) started on the 1st of October 2012 and is now in its 3rd year of implementation.
Every year, representatives from Ministries of Health, Regional Economic Communities (RECs), medicine advisors from WHO country offices, WHO staff from AFRO and headquarters involved in the RP implementation meet to review progress and facilitate the implementation of planned activities at country, sub-regional and regional level.
Specific topics of interest for countries or new subjects in relation to the global agenda on access to essential medicines are included in the agenda of these meetings.
The RP 3rd year meeting will be held from 29 June to 3rd July 2015, in Brazzaville, Congo. The meeting will be in two parts.
The first part of the meeting (29 and 30 June 2015) will bring together WHO medicines country advisors in charge of the day-to-day implementation of the RP, to provide them with feedback on the general overview of the implementation of the RP 2nd year plan and with the outcome of the mid-term review and the second Steering Committee with the European Commission. This part of the meeting will further discuss the role of WHO medicines advisors in countries and more particularly in the policy dialogue necessary in the pharmaceutical sector.
The second part of the meeting (1st to 3rd July 2015) will bring together representatives of Ministries of Health, RECs and WHO medicine advisors involved in the RP implementation. During this meeting, the representatives will share information on progress made in countries with the implementation of activities identified for the 3rd year RP plan; will share experiences, opportunities and challenges and foster a strategy to enhance implementation of agreed activities to achieve RP objectives and expected results. The meeting will address modalities to further increase the visibility of the RP in countries.
Training sessions and discussions will also be organized on specific topics including:
Good governance and transparency in the pharmaceutical sector,
Development of pricing and reimbursement policies within national health insurance systems as part of the Universal Health Coverage agenda,
Selection of essential medicines,
National procurement systems.
For more information please contact:
Abayneh Tamir Desta
Email: destaa [at] who.int
Tel: +47241 39262